Skip to content

A multicenter, randomized, double-blind, placebo-controlled clinical trial of the efficacy of probiotic intervention in preventing the conversion of impaired glucose tolerance (IGT) to type 2 diabetes mellitus

A multicenter, randomized, double-blind, placebo-controlled clinical trial of the efficacy of probiotic intervention in preventing the conversion of impaired glucose tolerance (IGT) to type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13004024
Enrollment
Unknown
Registered
2013-12-23
Start date
2014-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired glucose tolerance, Type 2 diabetes mellitus

Interventions

treatment group:oral probiotic
control group:oral placebo

Sponsors

Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, China.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 35-65 years; 2. Diagnose IGT after OGTT, no serious heart, liver, kidney, lung dysfunction; 3. Informed consent; 4. Agreement on no other drug therapy on IGT during trial.

Exclusion criteria

Exclusion criteria: 1. No serious heart, liver, kidney, lung dysfunction, no diabetes; 2. Probiotic allergy; 3. Suspected or confirmed history of alcohol, drug abuse, or may change the work environment frequently according to the investigator's judgment; 4. Have participated in other clinical trials in the past three months; 5. Some other possible situations not suitable to this trial judged by observers.

Design outcomes

Primary

MeasureTime frame
blood glucose;

Secondary

MeasureTime frame
lipids;

Countries

China

Contacts

Public ContactBo Feng

Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, China.

fengbo@medmail.com.cn+86 13301921056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026